Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13694 | 819 | 45.9 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
71 | 3 | GENETICS & HEREDITY//CHROMATIN//CELL BIOLOGY | 83302 |
343 | 2 | EZH2//CHROMATIN//POLYCOMB | 17754 |
13694 | 1 | BROMODOMAIN//BRD4//NUT MIDLINE CARCINOMA | 819 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BROMODOMAIN | authKW | 2533593 | 14% | 59% | 116 |
2 | BRD4 | authKW | 1475780 | 7% | 65% | 61 |
3 | NUT MIDLINE CARCINOMA | authKW | 1201857 | 4% | 92% | 35 |
4 | JQ1 | authKW | 1037958 | 4% | 80% | 35 |
5 | BET INHIBITORS | authKW | 489746 | 2% | 77% | 17 |
6 | ATAD2 | authKW | 441494 | 2% | 79% | 15 |
7 | BRD2 | authKW | 381759 | 2% | 64% | 16 |
8 | BET PROTEINS | authKW | 332141 | 2% | 64% | 14 |
9 | BRD4 NUT | authKW | 301985 | 1% | 90% | 9 |
10 | BRDT | authKW | 255640 | 1% | 57% | 12 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 2267 | 28% | 0% | 228 |
2 | Chemistry, Medicinal | 1965 | 15% | 0% | 123 |
3 | Oncology | 1346 | 22% | 0% | 183 |
4 | Biochemistry & Molecular Biology | 1080 | 32% | 0% | 266 |
5 | Pathology | 161 | 5% | 0% | 38 |
6 | Genetics & Heredity | 109 | 6% | 0% | 51 |
7 | Developmental Biology | 97 | 3% | 0% | 21 |
8 | Biophysics | 95 | 5% | 0% | 41 |
9 | Hematology | 43 | 3% | 0% | 25 |
10 | Pharmacology & Pharmacy | 19 | 6% | 0% | 46 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPINOVA DPU | 224448 | 2% | 35% | 17 |
2 | STRUCT GENOM CONSORTIUM | 180388 | 8% | 8% | 64 |
3 | TARGET DISCOVERY | 171648 | 4% | 14% | 34 |
4 | CELLZOME GMBH | 170426 | 1% | 57% | 8 |
5 | EPINOVA DISCOVERY PERFORMANCE UNIT | 162086 | 1% | 43% | 10 |
6 | EPINOVA | 119302 | 0% | 80% | 4 |
7 | EPINOVA EPIGENET DISCOVERY PERFORMANCE UNIT | 111847 | 0% | 100% | 3 |
8 | BUCHMANN LIFE SCI | 103557 | 1% | 56% | 5 |
9 | MOL GROWTH REGULAT | 92989 | 3% | 11% | 23 |
10 | CANC EPIGENET DPU | 85213 | 0% | 57% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF MEDICINAL CHEMISTRY | 4827 | 6% | 0% | 53 |
2 | MEDCHEMCOMM | 4648 | 2% | 1% | 13 |
3 | ONCOTARGET | 3472 | 4% | 0% | 34 |
4 | CELL REPORTS | 2548 | 2% | 0% | 15 |
5 | ACS CHEMICAL BIOLOGY | 2478 | 1% | 1% | 12 |
6 | NATURE CHEMICAL BIOLOGY | 2188 | 1% | 1% | 9 |
7 | ACS MEDICINAL CHEMISTRY LETTERS | 1723 | 1% | 1% | 8 |
8 | LANCET HAEMATOLOGY | 1416 | 0% | 2% | 2 |
9 | MOLECULAR CELL | 1317 | 2% | 0% | 14 |
10 | CHEMMEDCHEM | 1303 | 1% | 0% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BROMODOMAIN | 2533593 | 14% | 59% | 116 | Search BROMODOMAIN | Search BROMODOMAIN |
2 | BRD4 | 1475780 | 7% | 65% | 61 | Search BRD4 | Search BRD4 |
3 | NUT MIDLINE CARCINOMA | 1201857 | 4% | 92% | 35 | Search NUT+MIDLINE+CARCINOMA | Search NUT+MIDLINE+CARCINOMA |
4 | JQ1 | 1037958 | 4% | 80% | 35 | Search JQ1 | Search JQ1 |
5 | BET INHIBITORS | 489746 | 2% | 77% | 17 | Search BET+INHIBITORS | Search BET+INHIBITORS |
6 | ATAD2 | 441494 | 2% | 79% | 15 | Search ATAD2 | Search ATAD2 |
7 | BRD2 | 381759 | 2% | 64% | 16 | Search BRD2 | Search BRD2 |
8 | BET PROTEINS | 332141 | 2% | 64% | 14 | Search BET+PROTEINS | Search BET+PROTEINS |
9 | BRD4 NUT | 301985 | 1% | 90% | 9 | Search BRD4+NUT | Search BRD4+NUT |
10 | BRDT | 255640 | 1% | 57% | 12 | Search BRDT | Search BRDT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JUNG, M , GELATO, KA , FERNANDEZ-MONTALVAN, A , SIEGEL, S , HAENDLER, B , (2015) TARGETING BET BROMODOMAINS FOR CANCER TREATMENT.EPIGENOMICS. VOL. 7. ISSUE 3. P. 487 -501 | 100 | 89% | 21 |
2 | FILIPPAKOPOULOS, P , KNAPP, S , (2014) TARGETING BROMODOMAINS: EPIGENETIC READERS OF LYSINE ACETYLATION.NATURE REVIEWS DRUG DISCOVERY. VOL. 13. ISSUE 5. P. 339 -358 | 85 | 56% | 210 |
3 | GALDEANO, C , CIULLI, A , (2016) SELECTIVITY ON-TARGET OF BROMODOMAIN CHEMICAL PROBES BY STRUCTURE-GUIDED MEDICINAL CHEMISTRY AND CHEMICAL BIOLOGY.FUTURE MEDICINAL CHEMISTRY. VOL. 8. ISSUE 13. P. 1655 -1680 | 95 | 79% | 5 |
4 | ROMERO, FA , TAYLOR, AM , CRAWFORD, TD , TSUI, V , COTE, A , MAGNUSON, S , (2016) DISRUPTING ACETYL-LYSINE RECOGNITION: PROGRESS IN THE DEVELOPMENT OF BROMODOMAIN INHIBITORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 4. P. 1271 -1298 | 75 | 65% | 18 |
5 | FRENCH, CA , (2016) SMALL-MOLECULE TARGETING OF BET PROTEINS IN CANCER.ADVANCES IN CANCER RESEARCH, VOL 131. VOL. 131. ISSUE . P. 21 -58 | 102 | 82% | 1 |
6 | FERRI, E , PETOSA, C , MCKENNA, CE , (2016) BROMODOMAINS: STRUCTURE, FUNCTION AND PHARMACOLOGY OF INHIBITION.BIOCHEMICAL PHARMACOLOGY. VOL. 106. ISSUE . P. 1 -18 | 89 | 62% | 9 |
7 | WANG, CY , FILIPPAKOPOULOS, P , (2015) BEATING THE ODDS: BETS IN DISEASE.TRENDS IN BIOCHEMICAL SCIENCES. VOL. 40. ISSUE 8. P. 468 -479 | 83 | 73% | 18 |
8 | BRAND, M , MEASURES, AM , WILSON, BG , CORTOPASSI, WA , ALEXANDER, R , HOSS, M , HEWINGS, DS , ROONEY, TPC , PATON, RS , CONWAY, SJ , (2015) SMALL MOLECULE INHIBITORS OF BROMODOMAIN-ACETYL-LYSINE INTERACTIONS.ACS CHEMICAL BIOLOGY. VOL. 10. ISSUE 1. P. 22 -39 | 76 | 67% | 36 |
9 | THEODOULOU, NH , TOMKINSON, NCO , PRINJHA, RK , HUMPHREYS, PG , (2016) PROGRESS IN THE DEVELOPMENT OF NON-BET BROMODOMAIN CHEMICAL PROBES.CHEMMEDCHEM. VOL. 11. ISSUE 5. P. 477 -487 | 58 | 89% | 6 |
10 | YU, L , WANG, Z , ZHANG, Z , REN, XM , LU, XY , DING, K , (2015) SMALL-MOLECULE BET INHIBITORS IN CLINICAL AND PRECLINICAL DEVELOPMENT AND THEIR THERAPEUTIC POTENTIAL.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 15. ISSUE 8. P. 776 -794 | 79 | 80% | 5 |
Classes with closest relation at Level 1 |